| pubmed-article:9929144 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9929144 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:9929144 | lifeskim:mentions | umls-concept:C1704628 | lld:lifeskim |
| pubmed-article:9929144 | lifeskim:mentions | umls-concept:C0280100 | lld:lifeskim |
| pubmed-article:9929144 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:9929144 | lifeskim:mentions | umls-concept:C0009429 | lld:lifeskim |
| pubmed-article:9929144 | lifeskim:mentions | umls-concept:C0312418 | lld:lifeskim |
| pubmed-article:9929144 | lifeskim:mentions | umls-concept:C0208407 | lld:lifeskim |
| pubmed-article:9929144 | lifeskim:mentions | umls-concept:C0036667 | lld:lifeskim |
| pubmed-article:9929144 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:9929144 | lifeskim:mentions | umls-concept:C1627358 | lld:lifeskim |
| pubmed-article:9929144 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:9929144 | pubmed:dateCreated | 1999-4-13 | lld:pubmed |
| pubmed-article:9929144 | pubmed:abstractText | We examined the enhanced chemosensitivity of quiescent (Q) cells in solid tumors to cis-diamminedichloroplatinum (II) (cisplatin) by combined treatment with tirapazamine (TPZ) and mild heating. C3H/He and Balb/c mice bearing SCC VII and EMT6/KU tumors, respectively, received continuous administration of 5-bromo-2'-deoxyuridine (BrdU) for 5 days using implanted mini-osmotic pumps to label all proliferating (P) cells. TPZ was administered intraperitoneally 2 h before cisplatin injection and/or tumors were locally heated at 40 degrees C for 60 min immediately after cisplatin injection. Sixty minutes after cisplatin injection, the tumors were excised, minced and trypsinized. The tumor cell suspensions were incubated with cytochalasin-B (a cytokinesis blocker), and the micronucleus (MN) frequency in cells without BrdU labeling (= Q cells) was determined using immunofluorescence staining for BrdU. The MN frequency in total (P+Q) tumor cells was determined from the tumors that were not pretreated with BrdU. The sensitivity to cisplatin was evaluated in terms of the frequency of induced micronuclei in binuclear tumor cells (MN frequency). Other groups of tumor-bearing C3H/He and Balb/c mice not given BrdU were injected with 195mPt-radiolabeled cisplatin. In both tumor systems, the MN frequency in Q cells was lower than that in the total cells. TPZ and mild heat treatment elevated the MN frequency in total and Q cells in both tumor systems, and to a higher extent in Q cells. The combination of TPZ and mild heat treatment increased the MN frequency more markedly than treatment with either TPZ or mild heating alone. In total tumor cells, TPZ and mild heat treatment increased the MN frequency in EMT6/KU tumor cells more markedly than in SCC VII tumor cells. 195mPt-labeled cisplatin uptake into total tumor cells was increased by mild heat treatment but not by TPZ. The cisplatin-sensitivity of Q cells was lower than that of total cells in both tumor systems. TPZ was thought to sensitize Q cells by killing the hypoxic cells without influencing tumor blood flow, and mild hyperthermia appeared to sensitize Q cells by distributing more cisplatin with an increase in blood flow in solid tumors. | lld:pubmed |
| pubmed-article:9929144 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9929144 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9929144 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9929144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9929144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9929144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9929144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9929144 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9929144 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9929144 | pubmed:issn | 0288-2043 | lld:pubmed |
| pubmed-article:9929144 | pubmed:author | pubmed-author:OnoKK | lld:pubmed |
| pubmed-article:9929144 | pubmed:author | pubmed-author:SuzukiMM | lld:pubmed |
| pubmed-article:9929144 | pubmed:author | pubmed-author:KawaiKK | lld:pubmed |
| pubmed-article:9929144 | pubmed:author | pubmed-author:NagasawaHH | lld:pubmed |
| pubmed-article:9929144 | pubmed:author | pubmed-author:AkaboshiMM | lld:pubmed |
| pubmed-article:9929144 | pubmed:author | pubmed-author:HoriHH | lld:pubmed |
| pubmed-article:9929144 | pubmed:author | pubmed-author:KasaiSS | lld:pubmed |
| pubmed-article:9929144 | pubmed:author | pubmed-author:UtaKK | lld:pubmed |
| pubmed-article:9929144 | pubmed:author | pubmed-author:MasunagaSS | lld:pubmed |
| pubmed-article:9929144 | pubmed:author | pubmed-author:KinashiYY | lld:pubmed |
| pubmed-article:9929144 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9929144 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:9929144 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9929144 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9929144 | pubmed:pagination | 441-8 | lld:pubmed |
| pubmed-article:9929144 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:meshHeading | pubmed-meshheading:9929144-... | lld:pubmed |
| pubmed-article:9929144 | pubmed:articleTitle | Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia. | lld:pubmed |
| pubmed-article:9929144 | pubmed:affiliation | Radiation Oncology Research Laboratory, Research Reactor Institute, Kyoto University, Osaka, Japan. | lld:pubmed |
| pubmed-article:9929144 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9929144 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9929144 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9929144 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9929144 | lld:pubmed |
